Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Gross Margin (2016 - 2025)

Historic Gross Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 61.19%.

  • Nephros' Gross Margin rose 1000.0% to 61.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.24%, marking a year-over-year increase of 22000.0%. This contributed to the annual value of 61.59% for FY2024, which is 25600.0% up from last year.
  • Nephros' Gross Margin amounted to 61.19% in Q3 2025, which was up 1000.0% from 63.25% recorded in Q2 2025.
  • Over the past 5 years, Nephros' Gross Margin peaked at 64.67% during Q1 2025, and registered a low of 31.63% during Q3 2022.
  • Its 5-year average for Gross Margin is 56.9%, with a median of 58.65% in 2023.
  • Its Gross Margin has fluctuated over the past 5 years, first crashed by -211200bps in 2022, then surged by 270000bps in 2023.
  • Over the past 5 years, Nephros' Gross Margin (Quarter) stood at 54.22% in 2021, then increased by 9bps to 58.99% in 2022, then grew by 5bps to 62.11% in 2023, then increased by 3bps to 63.95% in 2024, then decreased by -4bps to 61.19% in 2025.
  • Its Gross Margin was 61.19% in Q3 2025, compared to 63.25% in Q2 2025 and 64.67% in Q1 2025.